Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion

OBJECTIVE: Glioblastoma (GBM) is the most prevalent and aggressive adult primary cancer in the central nervous system. Therapeutic approaches for GBM treatment are under intense investigation, including the use of emerging immunotherapies. Here, we propose an alternative approach to treat GBM throug...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Pei, Zifei, Hossain, Aasma, Bai, Yuting, Chen, Gong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330525/
https://www.ncbi.nlm.nih.gov/pubmed/33755378
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330525/
https://www.ncbi.nlm.nih.gov/pubmed/33755378
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0499

Ejemplares similares